Recombinant Cytomegalovirus Cytomegalovirus gH Pentamer Complex VR1814 His (C-Term) Protein

Images

 
SDS-Page: Cytomegalovirus gH Pentamer Complex Recombinant Protein Antigen [NBP3-14809] - Coomassie-stained SDS-PAGE showing Cytomegalovirus gH Pentamer Complex.

Product Details

Summary
Reactivity VSpecies Glossary
Applications PAGE

Order Details

Recombinant Cytomegalovirus Cytomegalovirus gH Pentamer Complex VR1814 His (C-Term) Protein Summary

Description
Recombinant human cytomegalovirus pentamer protein complex (NCBI Accession#: ACZ79986), consisting of proteins UL75 (gH), UL115 (gL), UL128, UL130 and UL131A, contains a His-tag.

Concentration: 1.0-1.5mg/ml
Specificity
Cytomegalovirus gH Pentamer Complex comprises five viral proteins (gH, gL, UL128, UL130, and UL131A). This complex has been shown to bind our recombinant NRP-2 protein in ELISA.
Source
HEK293
Protein/Peptide Type
Recombinant Protein
Purity
>95% pure by SDS-PAGE

Applications/Dilutions

Dilutions
  • SDS-Page
Application Notes
Purified protein binds NRP-2 receptor in ELISA.

Reactivity Notes

Cytomegalovirus (VR1418 Strain)

Packaging, Storage & Formulations

Storage
Store at -80C. Avoid freeze-thaw cycles.
Buffer
Dulbecco's PBS, 0.2 um filter sterilised.
Preservative
No Preservative
Purity
>95% pure by SDS-PAGE

Alternate Names for Recombinant Cytomegalovirus Cytomegalovirus gH Pentamer Complex VR1814 His (C-Term) Protein

  • envelope glycoprotein H

Background

Human cytomegalovirus, also called HCMV or human herpesvirus 5, is a double-stranded DNA, enveloped virus of 230-250 kilobases (kb) that is a member of the Herpesviridae family and the subfamily Betaherpesvirinae (1,2). Other herpesviruses, which share the characteristic of lifelong latency following primary infection, include herpes simplex virus types 1 (HSV-1) and 2 (HSV-2), varicella zoster virus (VSV), and Epstein-Barr virus (EBV) (1). Cytomegalovirus entry into cells is mediated by a trimeric complex of glycoproteins gH, gL, and gO and a pentamer made of proteins gH, gL, UL128, UL130, and UL131A (1,3). The trimer binds PDGFRalpha for entry into fibroblasts while the pentamer binds neuropilin-2 for entry into endothelial and epithelial cells (1,4). Additionally, the fusion protein glycoprotein B (gB) plays a pivotal role for cytomegalovirus entry into the host cell membrane (1,3).

Cytomegalovirus is a common virus, infecting ~60% of adults in developed countries and over 90% in developing countries, as indicated by presence of specific IgG antibodies (2-4). Although a majority of people infected remain asymptomatic, immunocompromised people, organ transplant recipients, and fetuses and newborns are more susceptible to HCMV-associated diseases (1-4). Annually, up to 2% of newborns are born with HCMV, making it the most common congenital infection (2-4). Cytomegalovirus is known to cause sensorineural hearing loss (SNHL), mental retardation, chorioretinitis, skin lesions, as well as end organ disease (3,5). There are a few CMV therapeutics approved by FDA including valganciclovir and letermovir; however, despite some benefits, there is the need for new antivirals and combination therapies (5). Potential new treatment options include monoclonal antibodies and sirtuins (5).

References

1. Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry. Nat Rev Microbiol. 2021;19(2):110-121. https://doi.org/10.1038/s41579-020-00448-w

2. Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19(12):759-773. https://doi.org/10.1038/s41579-021-00582-z

3. Krstanovic F, Britt WJ, Jonjic S, Brizic I. Cytomegalovirus Infection and Inflammation in Developing Brain. Viruses. 2021;13(6):1078. Published 2021 Jun 4. https://doi.org/10.3390/v13061078

4. Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol. 2015;235(2):288-297. https://doi.org/10.1002/path.4437

5. Acosta E, Bowlin T, Brooks J, et al. Advances in the Development of Therapeutics for Cytomegalovirus Infections. J Infect Dis. 2020;221(Suppl 1):S32-S44. https://doi.org/10.1093/infdis/jiz493

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Publications for Cytomegalovirus gH Pentamer Complex Recombinant Protein (NBP3-14809) (0)

There are no publications for Cytomegalovirus gH Pentamer Complex Recombinant Protein (NBP3-14809).
By submitting your publication information earn gift cards and discounts for future purchases.

Reviews for Cytomegalovirus gH Pentamer Complex Recombinant Protein (NBP3-14809) (0)

There are no reviews for Cytomegalovirus gH Pentamer Complex Recombinant Protein (NBP3-14809). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for Cytomegalovirus gH Pentamer Complex Recombinant Protein (NBP3-14809) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Cytomegalovirus gH Pentamer Complex Products

Research Areas for Cytomegalovirus gH Pentamer Complex Recombinant Protein (NBP3-14809)

Find related products by research area.

Blogs on Cytomegalovirus gH Pentamer Complex

There are no specific blogs for Cytomegalovirus gH Pentamer Complex, but you can read our latest blog posts.

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Cytomegalovirus Cytomegalovirus gH Pentamer Complex VR1814 His (C-Term) Protein and receive a gift card or discount.